Agile Therapeutics | AGRX - Stock


Agile Therapeutics reported $1.33M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Adma Biologics USD 206.46M 9.8M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Grifols EUR 3.56B 63.19M Dec/2024
J&J USD 14.19B 45M Dec/2025
Merck USD 6.44B 157M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
TherapeuticsMD USD 6.7M 551K Sep/2022